The ANA Testing Market is segmented based on products, diseases, techniques, end users, and regions. On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global market, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.

The Antinuclear Antibody Test Market is segmented into five major disease segments, namely, rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma, and other diseases. Other diseases include Raynaud’s Syndrome, polymyositis, mixed connective tissue disease, drug-induced lupus, and autoimmune hepatitis. The rheumatoid arthritis segment is expected to account for the largest share of this market primarily due to the increasing incidence of rheumatoid arthritis.

Based on techniques, the ANA testing market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market majorly due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The global antinuclear antibody test market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest growth in the coming years, with the growth in this regional segment centered at China, Japan, and India.

The major players in this antinuclear antibody test market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst